AbCellera Biologics (ABCL) Return on Capital Employed Growth (1y) (2022 - 2026)
AbCellera Biologics (ABCL) Return on Capital Employed Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 472.04 Bn | 467.25 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.28 Bn | 115.03 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 56.16 Bn | 50.98 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn | 2,400.00 |
| 10 | AbCellera Biologics | 1.63 Bn | 1.63 Bn | - | 876.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 876.00 |
| Dec 31, 2025 | 741.00 |
| Sep 30, 2025 | 334.00 |
| Jun 30, 2025 | -164.00 |
| Mar 31, 2025 | -868.00 |
| Dec 31, 2024 | -704.00 |
| Sep 30, 2024 | -851.00 |
| Jun 30, 2024 | -1,138.00 |
| Mar 31, 2024 | -1,145.00 |
| Dec 31, 2023 | -3,233.00 |
| Sep 30, 2023 | -3,766.00 |
| Jun 30, 2023 | -2,800.00 |
| Mar 31, 2023 | -2,698.00 |
| Dec 31, 2022 | -302.00 |
| Sep 30, 2022 | -260.00 |
| Jun 30, 2022 | -928.00 |
| Mar 31, 2022 | -1,046.00 |